Terbinafine and potential drug interactions.
Kaplan
D L
DL
D000928:Antidepressive Agents / Q000009:adverse effects / Q000493:pharmacokinetics; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000493:pharmacokinetics; D019389:Cytochrome P-450 CYP2D6 / Q000187:drug effects* / Q000378:metabolism; D004347:Drug Interactions; D004791:Enzyme Inhibitors / Q000009:adverse effects* / Q000493:pharmacokinetics; D006801:Humans; D009281:Naphthalenes / Q000009:adverse effects* / Q000493:pharmacokinetics; D000077291:Terbinafine
D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D004791:Enzyme Inhibitors; D009281:Naphthalenes; D019389:Cytochrome P-450 CYP2D6; D000077291:Terbinafine